225 related articles for article (PubMed ID: 20421439)
41. In vitro activity of amphotericin B, itraconazole, voriconazole, posaconazole, caspofungin and terbinafine against Scytalidium dimidiatum and Scytalidium hyalinum clinical isolates.
Lacroix C; de Chauvin MF
J Antimicrob Chemother; 2008 Apr; 61(4):835-7. PubMed ID: 18218642
[TBL] [Abstract][Full Text] [Related]
42. A rare case of multiple brain abscess and probably disseminated phaeohyphomycosis due to Cladophialophora bantiana in an immunosuppressed individual from India.
Lahiri Mukhopadhyay S; Mahadevan A; Bahubali VH; Dawn Bharath R; Prabhuraj AR; Maji S; Siddaiah N
J Mycol Med; 2017 Sep; 27(3):391-395. PubMed ID: 28478966
[TBL] [Abstract][Full Text] [Related]
43. Genomic Analyses of Cladophialophora bantiana, a Major Cause of Cerebral Phaeohyphomycosis Provides Insight into Its Lifestyle, Virulence and Adaption in Host.
Kuan CS; Cham CY; Singh G; Yew SM; Tan YC; Chong PS; Toh YF; Atiya N; Na SL; Lee KW; Hoh CC; Yee WY; Ng KP
PLoS One; 2016; 11(8):e0161008. PubMed ID: 27570972
[TBL] [Abstract][Full Text] [Related]
44.
Gopalakrishnan R; Sethuraman N; Madhumitha R; Sukhwani K; Bansal N; Poojary I; Chakrabarti A
Indian J Med Microbiol; 2017; 35(4):620-622. PubMed ID: 29405163
[TBL] [Abstract][Full Text] [Related]
45. [Fungal infection by Cladophialophora bantiana and development of cerebral phaeohyphomycosis. A systematic review of 58 case reports].
Jara-Ortega P; Ordoñez-Apolo F; Jara-Ortega N; Jara-Crespo F
Rev Neurol; 2023 Oct; 77(8):185-196. PubMed ID: 37807883
[TBL] [Abstract][Full Text] [Related]
46. In Vitro Antifungal Susceptibility of Neoscytalidium dimidiatum Clinical Isolates from Malaysia.
James JE; Santhanam J; Lee MC; Wong CX; Sabaratnam P; Yusoff H; Tzar MN; Razak MF
Mycopathologia; 2017 Apr; 182(3-4):305-313. PubMed ID: 27815659
[TBL] [Abstract][Full Text] [Related]
47. In vitro susceptibility of 188 clinical and environmental isolates of Aspergillus flavus for the new triazole isavuconazole and seven other antifungal drugs.
Shivaprakash MR; Geertsen E; Chakrabarti A; Mouton JW; Meis JF
Mycoses; 2011 Sep; 54(5):e583-9. PubMed ID: 21518026
[TBL] [Abstract][Full Text] [Related]
48. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
Karabıçak N; Alem N
Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
[TBL] [Abstract][Full Text] [Related]
49. In vitro antifungal susceptibility of coelomycete agents of black grain eumycetoma to eight antifungals.
Ahmed SA; de Hoog GS; Stevens DA; Fahal AH; van de Sande WW
Med Mycol; 2015 Apr; 53(3):295-301. PubMed ID: 25631481
[TBL] [Abstract][Full Text] [Related]
50. Endogenous fungal endophthalmitis caused by Cladophialophora devriesii: report of a case and literature review.
Krohn J; Power ØA; Mylvaganam H; Askim AJ; Arnes JB; Blomberg B
J Ophthalmic Inflamm Infect; 2024 Jun; 14(1):25. PubMed ID: 38836962
[TBL] [Abstract][Full Text] [Related]
51. Molecular identification, biofilm formation and antifungal susceptibility of Rhodotorula spp.
Gharaghani M; Taghipour S; Zarei Mahmoudabadi A
Mol Biol Rep; 2020 Nov; 47(11):8903-8909. PubMed ID: 33130966
[TBL] [Abstract][Full Text] [Related]
52. In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods.
Diekema DJ; Messer SA; Boyken LB; Hollis RJ; Kroeger J; Tendolkar S; Pfaller MA
J Clin Microbiol; 2009 Oct; 47(10):3170-7. PubMed ID: 19710283
[TBL] [Abstract][Full Text] [Related]
53. Prevalence and Antifungal Susceptibility of the Emerging Fungal Species,
Sikora M; Kuthan R; Piskorska-Malolepsza K; Golas-Pradzynska M; Domański D; Augustynowicz-Kopeć E; Swoboda-Kopec E
Pol J Microbiol; 2019 Sep; 68(3):303-308. PubMed ID: 31880875
[TBL] [Abstract][Full Text] [Related]
54. Antifungal efficacy of isavuconazole and liposomal amphotericin B in a rabbit model of Exserohilum rostratum meningoencephalitis: A preclinical paradigm for management of CNS phaeohyphomycosis.
Petraitis V; Petraitiene R; Katragkou A; Maung BBW; Moradi PW; Sussman-Straus GE; Naing E; Kovanda LL; Finkelman MA; Walsh TJ
Med Mycol; 2021 Feb; 59(2):189-196. PubMed ID: 33313821
[TBL] [Abstract][Full Text] [Related]
55. Molecular characterization and antifungal susceptibility testing of Candida nivariensis from blood samples - an Iranian multicentre study and a review of the literature.
Arastehfar A; Daneshnia F; Salehi MR; Zarrinfar H; Khodavaisy S; Haas PJ; Roudbary M; Najafzadeh MJ; Zomorodian K; Charsizadeh A; Brouwer C; Pan W; Hagen F; Boekhout T
J Med Microbiol; 2019 May; 68(5):770-777. PubMed ID: 30924763
[TBL] [Abstract][Full Text] [Related]
56. Phaeohyphomycosis in a snow leopard (Uncia uncia) due to Cladophialophora bantiana.
Janovsky M; Gröne A; Ciardo D; Völlm J; Burnens A; Fatzer R; Bacciarini LN
J Comp Pathol; 2006; 134(2-3):245-8. PubMed ID: 16542676
[TBL] [Abstract][Full Text] [Related]
57. In vitro testing of susceptibilities of filamentous ascomycetes to voriconazole, itraconazole, and amphotericin B, with consideration of phylogenetic implications.
McGinnis MR; Pasarell L
J Clin Microbiol; 1998 Aug; 36(8):2353-5. PubMed ID: 9666022
[TBL] [Abstract][Full Text] [Related]
58. Cladophialophora Bantiana as a Cause of Rare Fungal Brain Abscess.
Ali Z; Usman M; Rehman U; Anwar F
J Coll Physicians Surg Pak; 2021 Sep; 31(9):1114-1116. PubMed ID: 34500534
[TBL] [Abstract][Full Text] [Related]
59. A CLADOPHIALOPHORA BRAIN ABSCESS IN A RENAL TRANSPLANT RECIPIENT.
Ray U; Dutta S; Chakravarty C
Southeast Asian J Trop Med Public Health; 2016 Sep; 47(5):1026-31. PubMed ID: 29620810
[TBL] [Abstract][Full Text] [Related]
60. [Antifungal susceptibilities of Aspergillus spp. strains isolated from invasive aspergillosis cases].
Gürcan S; Tikveşli M; Eryildiz C; Evci C; Ener B
Mikrobiyol Bul; 2010 Apr; 44(2):273-8. PubMed ID: 20549962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
